Not recruiting
Adult T-cell lymphoma/leukaemia+2
Not recruitingStudy of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas
Registered drugNo placebo
Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas
Registered drugNo placebo
- Disease:Adult T-cell lymphoma/leukaemiaAdult T-cell lymphoma/leukaemia recurrent+1
- Substances:EtoposideIfosfamide+2
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Etoposide
- Sponsor:Fondazione IRCCS Istituto Nazionale Dei Tumori